SGLT2 Inhibitors Safe for HF in Congenital Heart Disease SGLT2 Inhibitors Safe for HF in Congenital Heart Disease

SGLT2 inhibitors not only were safe in adult patients with congenital heart disease who develop heart failure but also were associated with reduced hospitalizations.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Source Type: news